SP
BravenNow
🏒
🌐 Entity

Proteolysis targeting chimera

Small molecule (PROTAC)

πŸ“Š Rating

1 news mentions Β· πŸ‘ 0 likes Β· πŸ‘Ž 0 dislikes

πŸ“Œ Topics

  • Corporate governance (1)
  • Financial markets (1)
  • Biotechnology industry (1)

🏷️ Keywords

Arvinas (1) Β· Cacace (1) Β· stock sale (1) Β· biotechnology (1) Β· insider trading (1) Β· regulatory filings (1) Β· NASDAQ (1)

πŸ“– Key Information

A proteolysis targeting chimera (PROTAC) is a molecule that can remove specific unwanted proteins. Rather than acting as a conventional enzyme inhibitor, a PROTAC works by inducing selective intracellular proteolysis. A heterobifunctional molecule with two active domains and a linker, PROTACs consist of two covalently linked protein-binding molecules: one capable of engaging an E3 ubiquitin ligase, and another that binds to a target protein.

πŸ“° Related News (1)

πŸ”— Entity Intersection Graph

Nasdaq(1)Cacace(1)Proteolysis targeting chimera

People and organizations frequently mentioned alongside Proteolysis targeting chimera:

  • Nasdaq
    Nasdaq Β· 1 shared articles
  • 🌐
    Cacace Β· 1 shared articles

πŸ”— External Links